Close Menu
    National News Brief
    Friday, November 20
    • Home
    • Business
    • Lifestyle
    • Science
    • Technology
    • International
    • Arts & Entertainment
    • Sports
    National News Brief
    Home » Congressional Conflicts: Lawmakers Dump Tylenol Stock Before Autism Controversy

    Congressional Conflicts: Lawmakers Dump Tylenol Stock Before Autism Controversy

    Team_NationalNewsBriefBy Team_NationalNewsBriefSeptember 29, 2025 Politics No Comments4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email




    Before President Donald Trump warned pregnant women to avoid taking Tylenol, three members of Congress dumped stock in the Fortune 500 company that makes the popular painkiller — sell-offs that saved them from incurring sizable losses, an investigation by The Center Square found.

    The lawmakers sold $1,001 to $15,000 each in Kenvue Inc., a Summit, New Jersey-based consumer products company that spun off from Johnson & Johnson two years ago. The sales are notable also because most investment analysts recommended that investors hold their shares.

    Among the three lawmakers is U.S. Rep. Scott Franklin, a Florida Republican, whose committee work overlapped with his reported sale of Kenvue stock on June 16, House financial disclosures show. He is the vice chairman of a House Appropriations subcommittee that oversees the budget of the Food and Drug Administration, the federal agency that regulates Tylenol.

    Franklin’s spokesperson did not return an email or phone call for comment.

    Craig Holman, a lobbyist for Public Citizen, a nonprofit, said the lawmakers’ sale of Kenvue’s stock before the Trump administration’s announcement on Sept. 22 raises questions about whether lawmakers had inside information. 

    “It’s a possible conflict of interest,” Holman said in an interview. “The fact that they sold prior to the public scandal suggests they might have traded on non-public information before the Trump administration lowered the hammer.” 

    Kenvue has come under fire for its use of acetaminophen, the primary active ingredient in Tylenol. In August, the Icahn School of Medicine at Mount Sinai, a private medical school in New York, reported that pregnant women who use acetaminophen may be at elevated risk of delivering babies with neurodevelopment disorders like autism and attention-deficit hyperactivity disorder. Other studies have found no connection.

    On September 12, the Wall Street Journal reported that Kenvue’s interim CEO, Kirk Perry, met with Health and Human Services Secretary Robert F. Kennedy, Jr., to argue against declaring a strong link between Tylenol use and autism. Perry’s lobbying effort came up short.

    A Kenvue spokeswoman said that “sound science clearly shows that taking acetaminophen does not cause autism.”

    On September 22, Kennedy announced that the government would issue a warning on Tylenol packages about the possible risks for pregnant women.

    Trump was blunt.

    “Don’t take Tylenol,” he said in a press conference at the White House. “Fight like hell not to take it.”

    Identifying possible conflicts of interest was a stated goal of a 2012 law known as the Stock Act. The law bars members of Congress, executive branch officials and their families from using information they discover in the course of their jobs for financial gain and requires them to file periodic transaction reports of trades worth more than $1,000 within 45 days. 

    Legislation to prohibit lawmakers from trading and owning stocks has never come up for a vote before the full House or Senate. On July 30, the Senate Homeland Security and Government Affairs advanced a bill from U.S. Sen. Josh Hawley, a Missouri Republican, that would do just that. Hawley’s legislation, like companion bills in the House, would permit lawmakers to own mutual funds.

    No lawmaker has been prosecuted for violating the law.

    In 2018, the Securities and Exchange Commission charged U.S. Rep. Chris Collins, a New York Republican, with insider trading. A member of the board of directors of a publicly traded Australian firm, Collins was accused of informing his son, a stock owner, that the company’s top product had failed a clinical trial before the news was public, the charges show. A year later, Collins pleaded guilty to one count of conspiracy to commit securities fraud, according to the U.S. Department of Justice.

    Franklin reported that through a joint account with his wife, the couple sold $1,001 to $15,000 of Kenvue stock on June 16, according to a filing with the U.S. Office of the Clerk. 

    U.S. Rep. Ro Khanna, a California Democrat, reported that his wife, Ritu Ahuja Khanna, sold stock in Kenvue through a blind trust on August 26, his filing showed. The sale came three weeks after she bought $1,001 to $15,000 worth of the stock, on August 4.

    Spokeswoman Sarah Drory declined to comment.

    The third lawmaker who reported dumping Kenvue’s stock is Sen. Sheldon Whitehouse, a Rhode Island Democrat, through his wife, Sandra Thornton Whitehouse. A spokeswoman did not return a voicemail and email for comment.

    None of the three lawmakers sold Kenvue stock alone on a single day. Each lawmaker reported selling the stock among his trades. Khanna reported that his wife via a blind trust bought 53 stocks and sold 51 on Aug. 26.

    The lawmakers’ sales proved timely. Since June, Kenvue’s stock price has plunged more than 20 percent.

    Syndicated with permission from The Center Square.



    Source link

    Team_NationalNewsBrief
    • Website

    Keep Reading

    Padres Meet With Top Free Agent Tarik Skubal

    Scottie Barnes Removed From Injury Report

    Westhill vs. St. Joseph and Bushland vs. Paradise Football Previews

    SK Hynix Leads Pre-Market Gains in Data Storage Stocks

    Roseanne Barr Helps Grandson Come Out on Podcast

    Diego Pavia Goes No. 1 in UFL Draft to Columbus Aviators

    Add A Comment

    Comments are closed.

    Editors Picks

    Renaming AI doesn’t make it any less of a threat to writers like me

    October 24, 2026

    US Military Raises Age Of Enlistment

    March 27, 2026

    Nelson Peltz Just Offered $1.4 Billion to Take Wendy’s Private

    October 29, 2026

    Commentary: These World Cup tweets show how AI will unite us all

    July 19, 2026

    Trump White House probes Harvard University’s scholar exchange programme | Donald Trump News

    July 23, 2025
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    About us

    Welcome to National News Brief, your one-stop destination for staying informed on the latest developments from around the globe. Our mission is to provide readers with up-to-the-minute coverage across a wide range of topics, ensuring you never miss out on the stories that matter most.

    At National News Brief, we cover World News, delivering accurate and insightful reports on global events and issues shaping the future. Our Tech News section keeps you informed about cutting-edge technologies, trends in AI, and innovations transforming industries. Stay ahead of the curve with updates on the World Economy, including financial markets, economic policies, and international trade.

    Editors Picks

    Victory – But At What Prices

    November 20, 2026

    Padres Meet With Top Free Agent Tarik Skubal

    November 20, 2026

    GTA 6’s Numbers Are Almost Too Wild To Believe

    November 20, 2026

    Cincinnati Zoo’s Fiona the hippo dies after failed effort to remove swallowed hat

    November 20, 2026
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us
    Copyright © 2024 Nationalnewsbrief.com All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.